Switching to brexpiprazole, a partial dopamine D2 receptor agonist, from previous antipsychotics in Japanese patients with schizophrenia: A post-hoc analysis of the Japanese long-term study (Part 2)

Jun ISHIGOOKA

Presentation information

[CNP] Poster Session

CNP » [CNP] Poster Session

[CNP_P10] Poster Session 10

Sat. Oct 12, 2019 4:40 PM - 5:25 PM Poster Hall (Multi-purpose Hall)

座長：住吉　太幹（国立精神・神経医療研究センター精神保健研究所児童・予防精神医学研究部）

5:04 PM - 5:12 PM

[CNP-P10-4] Switching to brexpiprazole, a partial dopamine D2 receptor agonist, from previous antipsychotics in Japanese patients with schizophrenia: A post-hoc analysis of the Japanese long-term study (Part 2)

^○Jun ISHIGOOKA¹, Ken INADA², Kazuo AOKI³, Kazunari NIIDOME³, Shuichi IWASHITA³, Tomohiro USAMI³ (1. Institute of CNS Pharmacology, Japan, 2. Tokyo Women's Medical University, 3. Otsuka Pharmaceutical Co., Ltd.)

Abstract password authentication.
Password to browse/download the abstracts has been sent to pre-registrants by email and printed on name badge. It is also indicated in the abstract booklet.